A retrospective study of nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
Latest Information Update: 29 Mar 2023
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
Most Recent Events
- 29 Mar 2023 New trial record
- 18 Feb 2023 Results presented at the 2023 Genitourinary Cancers Symposium